نتایج جستجو برای: peripheral blood stem cell transplantation

تعداد نتایج: 2490817  

Journal: :international journal of hematology-oncology and stem cell research 0
amir ali hamidieh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran kamran alimoghaddam hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran arash jalali hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran afsaneh alimohammadi hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran

introduction: neuroblastoma is the most common extracranial solid tumor in children, accounting for 8% to 10% of all childhood cancers. significantly, autologous transplantation appeared to have the largest impact on survival for the high risk subset of patients, such as those with n-myc amplified metastatic disease diagnosed after age 2 years. patients and methods: this study includes high ris...

Journal: :international journal of hematology-oncology and stem cell research 0
saeed mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ashraf malek mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohsen nikbakht hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hossein norooznezhad hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

peripheral blood stem cell transplantation (pbsct) is an effective treatment for hematological malignancies. mobilization of peripheral blood progenitor cells performs in different ways among transplantation centers. forceful mobilization schedules are comprised of growth factor alone, chemotherapy along with growth factor and also, a newly combination of novel agent such as plerixafor with any...

Journal: :acta medica iranica 0
a. ghavamzadeh m. iravani m. jahani b. bahar a. mousavi s. gholibeikian

in this center, from 1991 to 2002, 89 chronic myelogenous leukemic (cml) patients, age ranging between 8-48 years with a median age of 29, underwent hematopoietic stem cell transplantation. eighty-eight patients were in the first chronic phase of disease. twenty-three patients received bone marrow transplantation (bmt) and 66 patients received peripheral blood stem cell transplantations (pbsct)...

Journal: :international journal of hematology-oncology and stem cell research 0
a ghavamzadeh hematology-oncology & bmt research center, tehran university of medical sciences shariati hospital tehran, iran b bahar hematology-oncology & bmt research center, tehran university of medical sciences shariati hospital tehran, iran m iravani hematology-oncology & bmt research center, tehran university of medical sciences shariati hospital tehran, iran m jahani hematology-oncology & bmt research center, tehran university of medical sciences shariati hospital tehran, iran s gholibeikian hematology-oncology & bmt research center, tehran university of medical sciences shariati hospital tehran, iran l eghbal hematology-oncology & bmt research center, tehran university of medical sciences shariati hospital tehran, iran

from 1996 to 2002, fifty three patients with major beta-thalassemia received allogeneic peripheral blood stem cell trans plantation (pbsct). median age was 6 years .twenty two were class i, 17 class ii and 14 class iii. all of the donors were hla-identical. conditioning regimen for class i and ii patients consisted of cyclophosphamide (cy) 50 mg/kg/day for 4 days + busulfan (bu) 3.5 mg/kg for 4...

Journal: :international journal of hematology-oncology and stem cell research 0
mona kargar research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. alireza ahmadvand research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. milad ahmadvand research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. molouk hadjibabaie research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. kheirollah gholami research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. seyed hamid khoee research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran.

background: invasive fungal infections (ifis) are chief infectious complications in patients undergoing hematopoietic stem cell transplantation (hsct). however, the diagnosis of fungal infections is difficult, and often empiric treatment initiates. since there is no data available on the prevalence of antifungal drugs administration in allogeneic hsct recipients in iran, we decided to conduct t...

Ali Akbar Pourfathoolah Ardeshir Ghavamzadeh Kamran Alimoghadam Mahin Nikougoftar Nahid Naderi Seyed Mohammad Moazzeni,

Background: Dendritic cells (DCs) are the most potent stimulators of primary T cell responses and play a key role in immune reactions after stem cell transplantation. Very little is known about the cord blood (CB) dendritic cells and their potential involvement in the low incidence and lower severity of acute graft-versus-host disease after CB transplantation.   Objectives: The aim of this stud...

Journal: :iranian journal of immunology 0
nahid naderi immunology department, tarbiat modarres university, tehran, iran ali akbar pourfathoolah immunology department, tarbiat modarres university, tehran, iran mahin nikougoftar iranian blood transfusion organization research center kamran alimoghadam hematology, oncology and bmt research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology, oncology and bmt research center, tehran university of medical sciences, tehran, iran seyed mohammad moazzeni immunology department, tarbiat modarres university, tehran, iran

background: dendritic cells (dcs) are the most potent stimulators of primary t cell responses and play a key role in immune reactions after stem cell transplantation. very little is known about the cord blood (cb) dendritic cells and their potential involvement in the low incidence and lower severity of acute graft-versus-host disease after cb transplantation.   objectives: the aim of this stud...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran kamran alimogaddam hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran amirali hamidieh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran seyed asadollah mousavi hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: this review reports the current results of hematopoietic stem cell transplantation (hsct) in patients who had received transplantation in the hematology-oncology and sct research center, tehran, iran. methods: in iran, from 1991 through 2010, a total of 3170 hematopoietic stem cell transplantation have been carried out. the male/female patient ratio was 1909/1261 with a median age...

Journal: :international journal of hematology-oncology and stem cell research 0
arash jalali department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran ; hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran. kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran. mahmood mahmoudi department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. kazem mohammad department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. hojjat zeraati department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. seied asadollah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran.

the aim of this study was to assess the predictive effect of the ebmt risk score on the outcomes of allogeneic stem cell transplantation in a relatively homogenous group of acute myelogenous leukemia (aml) patients regarding the occurrence of acute and chronic graft versus host disease (gvhd). this historical cohort study included adult patients (≥ 15 years old) with aml (n=363) who received al...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: acute myelogenous leukemia (aml) is a clonal  malignant disease of hematopoietic tissue. the early use of  hematopoietic stem cell transplantation (hsct) for aml was for patients with advanced stages of disease, usually while in relapse, in second or subsequent remission, or with resistant disease. patients and methods: from march 1991 until february 2008, 356(65%) registered allo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید